
Dyne Therapeutics, Inc.
USD17.99
+0.75 (+4.35%)
CEO
John G. Cox
IPO Date
2020-09-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$17.27
Prev. Close
$17.24
Day Low
$17.19
Day High
$18.07
52W Low
$8.06
52W High
$25.00
Market Cap
$2.97B
Volume
1.52M
| 3 Mar 2026 |
| HC Wainwright & Co. |
| Buy |
| Buy |
| maintain |
| 3 Mar 2026 | Chardan Capital | Buy | Buy | maintain |
| 3 Mar 2026 | Morgan Stanley | Overweight | Overweight | maintain |
| 20 Jan 2026 | JP Morgan | Neutral | Neutral | maintain |
| 15 Dec 2025 | Evercore ISI Group | Outperform | Outperform | maintain |
| 11 Dec 2025 | Stifel | Buy | Buy | maintain |
| 10 Dec 2025 | Oppenheimer | Perform | Outperform | upgrade |